|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 320 GBX | +0.79% |
|
+1.27% | +45.45% |
| May. 09 | Avon Protection wins UK MoD supply deal; Molten Ventures up | AN |
| May. 09 | Molten Ventures wins UK MoD supply contract | AN |
Oxford Biomedica plc reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was GBP 43.06 million compared to GBP 64.03 million a year ago. Net loss was GBP 47.96 million compared to GBP 25.48 million a year ago.
Basic loss per share from continuing operations was GBP 0.4974 compared to GBP 0.2729 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +45.45% | 399M | |
| +5.33% | 111B | |
| +12.11% | 105B | |
| -12.56% | 22.34B | |
| -3.70% | 21.93B | |
| -6.03% | 18.59B | |
| -35.21% | 18.12B | |
| -10.86% | 16.96B | |
| +5.10% | 13.7B | |
| +37.57% | 12.45B |
OXFORD BIOMEDICA PLC 